| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.049 | 0.8 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |